Highlights from SABCS 2025
Meeting Mic
In this episode of Meeting Mic, we bring you the highlights and insights from the San Antonio Breast Cancer Symposium 2025, as well as Healio’s top headlines from the meeting. Amy Comander, MD, DipABLM, FACLM, MSCP, highlights presentations at this year’s meeting. :26 Jun J. Mao, MD, MSCE, discusses results from a phase 2 trial surrounding acupuncture for breast cancer. 1:50 Amanda M. Woodworth, MD, FACS, CPE, describes a digital toolkit for advancing risk-informed breast cancer screening. 4:41 Read the full coverage here: Disclosures: Comander reports no relevant financial...
info_outline
Highlights from NEI 2025
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 Neuroscience Educational Institute (NEI) Annual Congress. David W. Goodman, MD, LFAPA, discusses his presentation about ADHD in adults including diagnosis, treatment and the current challenges. :22 Katherine Dahlsgaard, PhD, ABPP, talks about her presentations on behavioral interventions for sleepy adolescents as well as the challenges physicians face in prescribing psychiatric medicines. 5:43 Kari L. Franson, PharmD, PhD, BCPP, FNAP, highlights her presentations on the current status of prescription digital...
info_outline
Highlights from GAPNA 2025
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 Gerontological Advanced Practice Nurses Association (GAPNA) Annual Conference. Kimberly Posey, AGPCNP-BC, DNP, PhD, GS-C, discusses the purpose for the meeting, and highlights from this year’s conference. :19 George Peraza-Smith, DNP, A-GNP-C, GNP-BC, GS-C, CNE, FAANP, immediate past president of GAPNA, provides an overview on popular presentations from the meeting, and goals for the future of the organization. 12:25 Disclosures: Healio was unable to confirm relevant disclosures at the time of publication.
info_outline
Highlights from ASRS 2025
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Society of Retina Specialists annual meeting, as well as Healio’s top headlines from the meeting. Andrew G. Lee, MD, discusses when retina experts should refer patients to a neuro-ophthalmologist. 0:29 Sunir J. Garg, MD, FACS, FASRS, provides an overview of lessons learned from two complex surgical cases. 1:52 Sunir J. Garg, MD, FACS, FASRS, overviewed key findings from the Global Trends in Retina Survey. 5:16 Michael O’Rouke talks collaborating with Boehringer Ingelheim to develop...
info_outline
Highlights from ASCO Annual Meeting 2025
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 ASCO Annual Meeting, as well as Healio’s top headlines from the meeting. Chinmay Jani, MD, discusses findings highlighting how alcohol-related cancer mortality has risen sharply over the past few decades. :19 Rachel I. Vogel, PhD, provides and overview on factors contributing to the time burden cancer care places on patients. 3:02 Alexander D. Sherry, MD, discusses how improvements in OS or quality of life after phase 3 oncology trials are based on improvements in unvalidated alternative...
info_outline
Highlights from AAN 2025
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Academy of Neurology Annual Meeting. Mary A. O'Neal, MD, FAAN, and Ratna K. Bhavaraju-Sanka, MD, FAAN, discuss their efforts to address the lack of access to neurological care by partnering with primary care. :34 Merit E. Cudkowicz, MD, MSc, FAAN, speaks with Healio about being honored The American Academy of Neurology’s Lifetime Achievement Award for her extensive work in ALS research. 2:50 Read the full coverage here: Source: Grossberg G, et al. Efficacy and safety of AXS-05 in Alzheimer's...
info_outline
Highlights from ASH 2024, Leukemia Edition (Continued)
Meeting Mic
In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition with a focus on leukemia, as well as Healio’s top headlines from the meeting. Aaron T. Gerds, MD, MS, discusses how socioeconomic disparities affect access to allogeneic hematopoietic stem cell transplantation for people with acute myeloid leukemia. :24 Hua Zhang, MD, PhD, reviews findings of bicistronic chimeric antigen receptor T-cell therapy induced durable response for most children with relapsed or refractory B-lineage acute lymphoblastic leukemia. 6:29 Moath Albliwi, MD,...
info_outline
Highlights from SABCS 2024
Meeting Mic
In this episode of Meeting Mic, we bring you the highlights and insights from the San Antonio Breast Cancer Symposium 2024, as well as Healio’s top headlines from the meeting. Judy Garber, MD, MPH, chief of the division of cancer genetics and prevention at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School, reviews results of the OlympiA trial. :25 Raza Hoda, MD, a pathologist at Cleveland Clinic and assistant professor of pathology at Cleveland Clinic Lerner College of Medicine, discusses results from the DESTINY-Breast04 and DESTINY-Breast06 trials. 1:55...
info_outline
Highlights from ASH 2024
Meeting Mic
In this episode of Meeting Mic, we bring you expert insights from the ASH Annual Meeting and Exhibition, as well as Healio’s top headlines from the meeting. Gwen L. Nichols, MD, reviews a panel discussion on how hematologists and oncologists can best address patients’ concerns as AI’s role in medicine invariably expands. :24 Thomas G. Knight, MD, addresses financial toxicity for people with blood cancer. 6:29 Charles S. Abrams, MD, discusses results of the HIBISCUS trial and its implications for vaso-occlusive events. 16:30 Read the full coverage here: Disclosures: Abrams...
info_outline
Highlights from AAO 2024
Meeting Mic
In this episode of Meeting Mic, we bring you pearls and perspectives from the American Academy of Ophthalmology 2024 Meeting with a focus on AMD and retina. David A. Eichenbaum, MD, discusses results from a phase 1 trial investigating axitinib for the treatment of neovascular age-related macular degeneration. :28 Douglas Love discusses the company’s phase 3 program in geographic atrophy. 2:37 Pravin U. Dugel, MD, discusses the next steps for the phase 3 SOL-1 and SOL-R studies. 3:54 Jeremiah Brown, MS, MD, presents results from the phase 4 Elevatum trial investigating faricimab for diabetic...
info_outlineIn this episode of Meeting Mic, we bring you pearls and perspectives from the 2025 American Academy of Neurology Annual Meeting.
Mary A. O'Neal, MD, FAAN, and Ratna K. Bhavaraju-Sanka, MD, FAAN, discuss their efforts to address the lack of access to neurological care by partnering with primary care. :34
Merit E. Cudkowicz, MD, MSc, FAAN, speaks with Healio about being honored The American Academy of Neurology’s Lifetime Achievement Award for her extensive work in ALS research. 2:50
Read the full coverage here:
ACCORD-2: AXS-05 delays relapse time to Alzheimer’s disease agitation
Source: Grossberg G, et al. Efficacy and safety of AXS-05 in Alzheimer's disease agitation: Results from ACCORD-2, a phase 3 randomized withdrawal double-blind placebo-controlled study. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.
Risk for ARIA driven by patient genotype, presence of hemorrhage in early Alzheimer’s
Source: Biffi A, et al. ARIA insights from the donanemab trials: Amyloid-targeted therapy in early symptomatic Alzheimer’s disease. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.
Microplastics in oceans may increase disability risk among coastal populations
Source: Ganatra S, et al. Marine microplastics levels and the prevalence of neurologic disability. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.
Nightmares may increase risk for early death
Source: Otaiku A, et al. Distressing dreams and risk of premature mortality: A population-based multicohort study. Presented at: American Academy of Neurology Annual Meeting; April 5-9, 2025; San Diego.
Disclosures:
Bhavaraju-Sanka reports serving as a consultant for Amgen and Argenx.
Cudkowicz reports financial relationships with AB Science, AC Immune SA, Aclipse, Annals of Neurology, Biogen, Coya Therapeutics, Cytokinetics, Eli Lilly, Immunity Pharma, InFlectis, Locust Walk, Novartis, Ono Pharmaceutical, Otsuka Pharmaceutical, Pasithea Therapeutics, Pontifax, Praxis Precision Medicine, Transposon, QurAlis, Regeneron, VectorY. She also reports receiving publishing royalties from a publication relating to health care. Her institution(s) received support from ALS Finding a Cure, ALS ONE, Biohaven, Calico, Clene Nanomedicine, Denali, ITB, Johnson & Johnson, the National Institute of Neurological Disorders and Stroke, PharmAust, Prilenia, Seelos, UCB/RA and Woolsley.
O’Neal reports serving as a consultant and excerpt witness for Circo; being an employee of Best Doctors; and receiving publishing royalties from a health care-related publication.